Enquire Now
Your Name
E-Mail
Mobile Number
Message
Send
About Trident Lifeline
Products
Pharmaceuticals
Tablets
Capsules
Liquid Orals
Oral Dry Powders
Topical Preparations
Dental Preparations
Nutraceuticals
Tablets
Capsules
Liquids
Sachets
Oral Spray
Effervescent Tablets
Global Presence
Investors
Board of Directors
Committees of Board of Directors
Key Managerial Personnel
Policies
Stock Exchange Submission
Disclosures
Board Meeting
Financial Results
Subsidiary Companies
TNS PHARMA PRIVATE LIMITED
Financial Information of Group Companies
Outstanding Dues to Creditors
Offer Documents
Draft Prospectus
Prospectus
Careers
Contact us
info@tridentlifeline.com
|
+91 261 2490224
About Trident Lifeline
Products
Pharmaceuticals
Tablets
Capsules
Liquid Orals
Oral Dry Powders
Topical Preparations
Dental Preparations
Nutraceuticals
Tablets
Capsules
Liquids
Sachets
Oral Spray
Effervescent Tablets
Global Presence
Investors
Board of Directors
Committees of Board of Directors
Key Managerial Personnel
Policies
Stock Exchange Submission
Disclosures
Board Meeting
Financial Results
Subsidiary Companies
TNS PHARMA PRIVATE LIMITED
Financial Information
of Group Companies
Outstanding Dues to Creditors
Offer Documents
Draft Prospectus
Prospectus
Careers
Contact us
Disclosures
Investors
Board of Directors
Committees of Board of Directors
KEY MANAGERIAL PERSONNEL
POLICIES
DISCLOSURES
BOARD MEETING
DRAFT PROSPECTUS
PROSPECTUS
FINANCIAL INFORMATION OF GROUP COMPANIES
OUTSTANDING DUES TO CREDITORS
TNS PHARMA PRIVATE LIMITED
Disclosure under Reg 29(2) of SEBI SAST, 2011_02.02.2023
Disclosure under Reg 29(2) of SEBI SAST, 2011_01.02.2023
Disclosure under Reg 29(2) of SEBI SAST, 2011_25.01.2023
Disclosure under Reg 29 (1) and (2) of SEBI(SAST), 2011_24.01.2023
Inadvertent Trade by Designated Person
Earning Presentation_Q3FY23
Disclosure under Reg 29 (1) and (2) of SEBI(SAST), 2011_23.01.2023
Disclosure under Regulation 29(2) and (3) of SEBI (SAST), 2011_21.01.2023
Newspaper Publication-Financial Results_18.01.2023
STATEMENT OF DEVIATION_31.12.2022
Certificate 74(5)_31.12.2022
Reconciliation of Share Capital Audit_31.12.2022
Non-Applicability of Corporate Governance Provisions_31.12.2022
IG_31.12.2022
SHP_31.12.2022
Intimation of Closure of Trading Window-30.12.2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 27-12-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 30-11-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 25-11-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 24-11-2022
Disclosure under Regulation 29(2) and (3) of SEBI(SAST),2011 - 17-11-2022
Intimation of Closure of Trading Window - 17-10-2022
Intimation of Acquisition of TNS Pharma Pvt. Ltd.